Credit Industriel ET Commercial lifted its holdings in Cross Country Healthcare, Inc. (NASDAQ:CCRN - Free Report) by 89.9% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 133,106 shares of the business services provider's stock after purchasing an additional 63,000 shares during the quarter. Credit Industriel ET Commercial owned 0.41% of Cross Country Healthcare worth $1,737,000 as of its most recent SEC filing.
Other institutional investors have also made changes to their positions in the company. Signaturefd LLC lifted its position in shares of Cross Country Healthcare by 139.9% in the second quarter. Signaturefd LLC now owns 2,193 shares of the business services provider's stock worth $29,000 after purchasing an additional 1,279 shares in the last quarter. Longfellow Investment Management Co. LLC bought a new stake in Cross Country Healthcare during the 1st quarter worth about $59,000. AlphaQuest LLC lifted its position in Cross Country Healthcare by 324.6% during the 1st quarter. AlphaQuest LLC now owns 8,297 shares of the business services provider's stock worth $124,000 after buying an additional 6,343 shares in the last quarter. Ballentine Partners LLC bought a new stake in Cross Country Healthcare during the second quarter worth about $166,000. Finally, Nomura Holdings Inc. bought a new stake in Cross Country Healthcare during the first quarter worth about $232,000. Institutional investors own 96.03% of the company's stock.
Wall Street Analyst Weigh In
Several analysts recently issued reports on the company. Barrington Research reiterated a "market perform" rating and set a $18.61 target price on shares of Cross Country Healthcare in a report on Tuesday, June 17th. Wall Street Zen upgraded Cross Country Healthcare to a "hold" rating in a research note on Saturday, August 9th. Finally, Weiss Ratings reaffirmed a "sell (d)" rating on shares of Cross Country Healthcare in a research report on Wednesday, October 8th. Six analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat, Cross Country Healthcare has a consensus rating of "Reduce" and an average target price of $17.93.
View Our Latest Analysis on Cross Country Healthcare
Cross Country Healthcare Trading Up 7.9%
CCRN opened at $12.50 on Tuesday. Cross Country Healthcare, Inc. has a 1-year low of $9.58 and a 1-year high of $18.33. The stock's fifty day simple moving average is $13.27 and its 200 day simple moving average is $13.46. The stock has a market cap of $409.50 million, a PE ratio of -48.08, a price-to-earnings-growth ratio of 6.92 and a beta of 0.39.
Cross Country Healthcare (NASDAQ:CCRN - Get Free Report) last posted its quarterly earnings results on Wednesday, August 6th. The business services provider reported ($0.01) earnings per share for the quarter, missing analysts' consensus estimates of $0.07 by ($0.08). The business had revenue of $274.07 million during the quarter, compared to the consensus estimate of $292.67 million. Cross Country Healthcare had a negative net margin of 0.70% and a positive return on equity of 1.72%. Equities analysts forecast that Cross Country Healthcare, Inc. will post 0.53 earnings per share for the current year.
Cross Country Healthcare Profile
(
Free Report)
Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cross Country Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cross Country Healthcare wasn't on the list.
While Cross Country Healthcare currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.